MDxHealth SA (MDXH) intrinsic value & 10-year financials
MDxHealth SA (MDXH) has a Graham intrinsic value of $55.14 per share. Over the last 8 fiscal years revenue grew 44.6% a year to $107.9M, with an average return on invested capital of 17.8%.
- Graham intrinsic value
- $55.14
- Revenue (FY2025)
- $107.9M
- Revenue growth (8-yr CAGR)
- 44.6%
- ROIC (10-yr avg)
- 17.8%
- Free cash flow (FY2025)
- -$3.3M
MDXH 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $107.9M | -$33.5M | -$0.67 | -$3.3M | -13.4% | -50.2% |
| FY2024 | $90.0M | -$38.1M | -$1.16 | -$19.7M | -27.5% | -124.5% |
| FY2023 | $70.2M | -$43.1M | $1.66 | -$24.2M | -38.9% | -111.3% |
| FY2022 | $37.1M | -$44.0M | $0.28 | -$36.9M | -102.3% | -351.4% |
| FY2021 | $22.2M | -$29.0M | -$0.00 | -$23.4M | -120.7% | 371.7% |
| FY2020 | $18.5M | -$28.7M | -$0.00 | -$20.8M | -146.9% | 372.3% |
| FY2019 | $11.8M | -$43.1M | -$0.01 | -$22.4M | -366.3% | — |
| FY2018 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
MDxHealth SA revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
MDxHealth SA has historically struggled to out-earn its cost of capital, averaging just -47.0% ROIC.
MDxHealth SA capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, MDxHealth SA is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $55.14 per share.